Default Theme
AIIMS NEW
अखिल भारतीय आयुर्विज्ञान संस्थान, नई दिल्ली
All India Institute Of Medical Sciences, New Delhi

Dr. Shalini Achra

                                                                                                               

 

 


1. Designation: Assistant Professor

2. Qualifications: MD (PSYCHIATRY), DM (ADDICTION PSYCHIATRY)

3. Email ID: This email address is being protected from spambots. You need JavaScript enabled to view it.

4. Field of Interest:

  • Consultation liaison addiction psychiatry

  • Capacity building in management of addictive disorders

5. Total number of publications till date: 47

6. Details of publications since 2010 onwards (the full citation)- these should be divided into journal  articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications)
Journal  articles (peer reviewed publications):

  1. Richa Tripathi, Shalini Singh, S. Sarkar, R. Lal and Y.P.S. Balhara (2021), "Pathway to care in co-occurring disorder and substance use disorder: an exploratory, cross-sectional study from India", Advances in Dual Diagnosis, Vol. ahead-of-print No. ahead-of-print. https://doi.org/10.1108/ADD-10-2020-0023

  2. Yatan Pal Singh Balhara, Shalini Singh, and Sanjay Kalra. "Pragmatic Opioid Use in Painful Diabetic Neuropathy." European Endocrinology 16.1 (2020): 21.

  3. Richa Tripathi, Shalini Singh, Roshan Bhad. The need, scope, challenges, and potential solutions for enhancing addiction psychiatry training in India. Indian J Psychiatry 2020;62:728-31

  4. Naveen K. Dhagudu,, Atul Ambekar, Alok Agrawal, Ravindra Rao, Ashwani K. Mishra, Raka Jain, and Shalini Singh. "Is there enough naloxone to deter the diversion? Effect of concurrent administration of intravenous naloxone on opioid agonist effects of intravenous buprenorphine: A randomised, double‐blind, within‐subject, crossover study among opioid‐dependent subjects." Drug and Alcohol Review (2020).

  5. Shalini Singh, Balhara, Y.P.S., Gupta, P. and Christodoulou, N.G. "Primary and secondary prevention strategies against illicit drug use among adults aged 18–25: a narrative review." Australasian Psychiatry 28.1 (2020): 84-90.

  6. Yatan Pal Singh Balhara and Shalini Singh. "Provisions for Health Sector Response to Substance Use Disorders in the Indian Policy: A Critique of the National Policy on Narcotic Drugs and Psychotropic Substances." Journal of Psychoactive Drugs 52.1 (2020): 93-100.

  7. Anju Dhawan & Shalini Singh. “ Social Dimensions of Substance Use Disorders” Social Psychiatry: Principles and Clinical Perspectives. (2019) 233-245

  8. Shalini Singh., Prasad, S., Bhatnagar, S., Lal, R., Choudhary, N. and Sahi, M.S. "A cross-sectional web-based survey of medical practitioners in India to assess their knowledge, attitude, prescription practices, and barriers toward opioid analgesic prescriptions." Indian journal of palliative care 25.4 (2019): 567.

  9. Yatan Pal Singh Balhara , Shalini Singh. Online course on basics of management of behavioral addictions involving use of internet: Observations from the first batch of participants. Asian J Psychiatr. 2019 Aug;44:1-3. doi: 10.1016/j.ajp.2019.07.013. Epub 2019 Jul 5. PMID: 31299581.

  10. Shalini Singh, Devika Kosana, and Rakesh Lal. "Long-term intentional Datura use and its consequences." Indian journal of psychiatry 61.5 (2019): 543-544.

  11. Rao R, Varshney M, Singh S, Agrawal A, Ambekar A. Mental Healthcare Act, 2017 and addiction treatment: Potential pitfalls and trepidations. Indian J Psychiatry 2019;61:208-12

  12. YPS Balhara, Shalini Singh, Siddharth Sarkar “Are the patients ready for the change?: An empirical study to evaluate the impact of change in formulation of buprenorphine- naloxone on prescription pattern, treatment adherence and patient satisfaction.” Substance Use and Misuse. 2018 Dec 4:1-8. doi: 10.1080/10826084.2018.1517799.

  13. Rakesh Lal, and Shalini Singh. “Assessment Tools for Screening and Clinical Evaluation of Psychosocial Aspects in Addictive Disorders.” Indian Journal of Psychiatry 60, no. 8 (January 1, 2018): 444. https://doi.org/10.4103/psychiatry. Indian Journal of Psychiatry_12_18.

  14. YPS Balhara, Harshwardhan M, Kumar R, Shalini Singh. “Extent and pattern of problematic internet use among school students from Delhi: Findings from the cyber awareness programme,” Asian Journal of Psychiatry (2018), https://doi.org/10.1016/j.ajp.2018.04.010

  15. Shalini Singh. “Illness Narratives of Substance Users from Urban India: The Untold Stories of Their ‘Afflictions.’” Medicine Anthropology Theory | An Open- Access Journal in the Anthropology of Health, Illness, and Medicine 4, no. 3 (September 28, 2017): 173. https://doi.org/10.17157/mat.4.3.484.

  16. Shalini Singh, Ganesh Kumar Mallaram, and Siddharth Sarkar. “Pathological Gambling: An Overview.” Medical Journal of Dr. D.Y. Patil University 10, no. 2 (March 1, 2017): 120. https://doi.org/10.4103/0975-2870.202105.

  17. Shalini Singh, and YPS Balhara. “A Review of Indian Research on Co- Occurring Cannabis Use Disorders& Psychiatric Disorders.” Indian Journal of Medical Research 146, no. 2 (February 1, 2017): 186. https://doi.org/10.4103/ijmr.IJMR_791_15.

  18. Shalini Singh & Siddharth Sarkar. “Benzodiazepine abuse among the elderly.” Journal of Geriatric Mental Health [serial online] 2016 [cited 2017 Mar 10]; 3:123-30. DOI: 10.4103/2348-9995.195605

  19. YPS Balhara, Shalini Singh, Modak T, Sarkar S. “A cross- sectional study to assess disability and its correlates among treatment seeking individuals with alcohol use disorders.” Indian Journal of Psychological Medicine 39 (2017): 40-5.

  20. YPS Balhara, Ashwani Mishra, Hem Sethi, Shalini Singh, and Sudhir Kumar Khandelwal. “Time Trends of Cannabis Use Among Treatment-Seeking Individuals at Government De-Addiction Centers Across India Over a Period of 7 Years.” Indian Journal of Psychological Medicine 38, no. 4 (2016): 331– 35. https://doi.org/10.4103/0253- 7176.185961.

  21. YPS Balhara, Shaul Lev-Ran, José Martínez-Raga, Amine Benyamina, Shalini Singh, Lisa Blecha, and Nestor Szerman. “State of Training, Clinical Services, and Research on Dual Disorders Across France, India, Israel, and Spain.” Journal of Dual Diagnosis 12, no. 3–4 (October 1, 2016): 252–60. https://doi.org/10.1080/15504263.2016.1254309.

  22. Shalini Singh, and YPS Balhara. “A Review of Indian Research on Co- Occurring Psychiatric Disorders and Alcohol Use Disorders.” Indian Journal of Psychological Medicine, Indian Journal of Psychological Medicine 38, 38, no. 1, 1 (February 2016): 10, 10–19. https://doi.org/10.4103/0253-7176.175089, 10.4103/0253-7176.175089.

  23. Shruti, Aggarwal, Shalini Singh, and Dinesh Kataria. “Knowledge, Attitude and Social Distance Practices of Young Undergraduates towards Mental Illness in India: A Comparative Analysis.” Asian Journal of Psychiatry 23 (October 1, 2016): 64–69. https://doi.org/10.1016/j.ajp.2016.07.012.

  24. YPS Balhara & Shalini Singh. “The relationship between schizophrenia, anti- psychotics and dysglycemia.” In "RSSDI-Annual Conference Update 2015". Chapter 91: 438-445.

  25. Budania, Satish Kumar, Monika Rathi, Shalini Singh, and Suresh Yadav. “Serum Cholesterol and Depression: A Puzzle Never Finished.” Journal of the Scientific Society 42, no. 2 (May 1, 2015): 59. https://doi.org/10.4103/0974- 5009.157023.

  26. Mina, Shaily, Masarat Jabeen, Shalini Singh, and Rohit Verma. “Gender Differences in Depression and Anxiety Among Atopic Dermatitis Patients.” Indian Journal of Dermatology 60, no. 2 (2015): 211. https://doi.org/10.4103/0019-5154.152564.

  27. Shalini Singh, SK Sinha, R Saha, Mukesh Jha, and DK Kataria. "Knowledge, attitude and practice related to tobacco use and cessation among young medical professionals." Indian Journal of Social Psychiatry 30, no. 1-2 (2014): 35-42.

  28. Buttar, Navtej S., Cathrine J. DeMars, Gwen Lomberk, Sumera Rizvi, Juliana Bonilla- Velez, Shalini Singh, Shahrooz Rashtak, Kenneth K. Wang, Martin E. Fernandez- Zapico, and Raul Urrutia. “Distinct Role of Kruppel-like Factor 11 in the Regulation of Prostaglandin E2 Biosynthesis.” The Journal of Biological Chemistry 285, no. 15 (April 9, 2010): 11433– 44. https://doi.org/10.1074/jbc.M109.077065.

Abstracts published in peer reviewed publications:

  1. Naveen K. Dhagudu, Atul Ambekar, Alok Agrawal, Ravindra Rao, Ashwani K. Mishra, Raka Jain, and Shalini Singh. " Is 4:1 Combination of Buprenorphine and Naloxone Really Deterrent Enough for Buprenorphine Diversion? A Double blind, Randomized, Crossover Design study.” Abstracts from the 2019 Annual Meeting of the International Society of Addiction Medicine (ISAM) in New Delhi, India and a thank you to the 2019 peer reviewers of Substance Abuse. 2020;40(1):50. SuppA2.

  2. Richa Tripathi, Singh Shalini, Sarkar Siddartha, Balhara YPS. “ On the Right Track? A comparative Study of Pathways to Care among Patients with Substance Use Disorders with and without Co- Occurring Psychiatric Disorders.” Abstracts from the 2019 Annual Meeting of the International Society of Addiction Medicine (ISAM) in New Delhi, India and a thank you to the 2019 peer reviewers of Substance Abuse. 2020;40(1):47. SuppA2.

  3. Naveen K. Dhagudu, Atul Ambekar, Alok Agrawal, Ravindra Rao, Ashwani K. Mishra, Raka Jain, and Shalini Singh. " Why do People Who Inject Drugs Dissolve Opioids in Pheniramine Maleate? A Randomized, Double-Blind Experimental Study.” Abstracts from the 2019 Annual Meeting of the International Society of Addiction Medicine (ISAM) in New Delhi, India and a thank you to the 2019 peer reviewers of Substance Abuse. 2020;40(1):23. SuppA2.

  4. Nandan Choudhary, Sushma Bhatnagar, Atul Ambekar, and Shalini Singh. “A cross- sectional study to measure rate of opioid use disorder in patients on long-term opioid analgesic therapy for management of chronic cancer pain. Oral Presentation Abstracts.” Indian Journal of Palliative Care 24, no. 2 (2018): 207–27. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915891/.

  5. Shalini Singh, YPS Balhara, Siddharth Sarkar. “Impact of change in buprenorphine- naloxone formulation on prescription pattern, treatment adherence and patient satisfaction among patients on buprenorphine maintenance treatment: A cross-sectional study Shalini Singh, YPS Balhara, Siddharth Sarkar . CPDD Annual Meeting Abstract Book (2018) pg. 73

  6. Shalini Singh, YPS Balhara, Rakesh Lal, Dinu Chandran, KK Deepak. “Reduced heart rate variability in alcohol use disorder: relationship with severity of depressive symptoms in post acute alcohol withdrawal state” Young Psychiatrist Award, Indian Journal of Psychiatry 60, Supplement 1 (February, 2018): 2.

  7. Shalini Singh, Sonali Jhanjee, Deepak Yadav. “Illness narratives of female substance users from an Indian urban slum: a clinical and social perspective on presentation and rehabilitation” College of Problems on Drug Dependence Annual Meeting Abstract Book (2017) pg. 325

  8. YPS Balhara, Tamunod Modak, Shalini Singh. “Can IDEAS be used to assess disability among individuals with alcohol use disorder?: Findings from a cross-sectional observational study Free papers.” Indian Journal of Social Psychiatry 32, no. 4 (2016): 407.

  9. Tamonud Modak, YPS Balhara, Shalini Singh. ”Correlation Between Severity of Alcohol Use Disorder And Disability Among Persons Seeking Treatment at A Tertiary Care Drug Dependence Treatment Center. Free Papers.” Indian Journal of Psychiatry 58, no. 5 (January 1, 2016): 41.

  10. Shalini Singh, Shruti Aggarwal, Suman Kumar Sinha, and Dinesh Kataria. "How are you feeling today doctor? -Mental wellbeing of young medical professionals: A cross- sectional analysis. Free papers (posters).” Indian Journal of Psychiatry 56, no. Suppl 1 (January 2014): S63–96. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943346/.

  11. Tarun Yadav & Shalini Singh. “Transient lesion in the splenium of corpus callosum in a case of acute psychosis with catatonia: pathophysiological hypothesis and literature review. RANZCP Abstracts.” Australian & New Zealand Journal of Psychiatry 47, no. 1_suppl (May 1, 2013): 1–98. https://doi.org/10.1177/0004867412486854.”. Australian & New Zealand Journal of Psychiatry 47 (May 2013): 1-98. 9.

7. Presentations made at scientific meetings/ conferences/ workshops

 

  1. Lecture series: Can a neighbourhood fall sick? Opioid addiction, collective violence, and currents of death in contemporary India in January, 2021. Organised by CSDS (Centre for Study of Developing Societies, India)

    1. Psychosocial aspects of opioid addiction in Indian urban slums

 

  1. Capacity Building on Standard Treatment Guideline for the Management of Substance Use Disorder, Government of Odisha. Training program held in January, 2021

    1. Opioid use disorder I

    2. Opioid use disorder II

    3. Stimulants and prescription drug misuse

 

  1. Programme on Orientation of Psychiatrists (Resource Persons) on Management of SUD, Ministry of Health and Family Welfare, October 2020

    1. Management of complicated alcohol withdrawal

 

  1. Wellness symposia for Undergraduate and postgraduate students: “MATE (Mind Activation Through Education)” AIIMS, AIIMS Student Wellness Program, throughout later half of 2020

    1. Types of drugs and accompanying problems

    2. Assessment of substance use disorders

    3. Tobacco cessation

    4. Quiz on wellness-drug abuse

 

  1. Project LEAD: training program for medical professionals on ‘Alcohol related Liver Diseases’, Institute of Liver and Biliary Sciences, September 2020

    1. Alcohol Use disorder counselling for Alcohol related Liver Diseases

 

  1. Nursing training programs

    1. Training of trainers program for AIIMS nurse educators, AIIMS & Lady Hardinge Medical College, held from 28th Nov. to 5th December 2019

      1. An introduction to addiction concept

      2. Opioid use disorders

      3. Long term management of opioid use disorders

      4. Management of nicotine dependence

    2. Training schedule of Holy Family Nursing Students at NDDTC, February, 2020:

      1. Opioid use disorders

      2. Long term management of opioid use disorders

      3. Clinical communication with patients and overcoming challenges

    3. Training of trainers program for AIIMS nurse educators held in February 2020

      1. Epidemiology of addictive disorders

      2. Introduction to behavioural addiction

  2. The XXI Annual Conference of the International Society of Addiction Medicine (2019):

    1. Symposium: Super-specialty courses in Addiction Psychiatry in India

    2. Symposium: Naltrexone implant in Addiction Psychiatry

 

8. Investigator in funded projects along with year completed:

None

9. Investigator in non-funded projects along with year and title ongoing:

None

10. Investigator in funded projects along with year and title ongoing:


None

11. Investigator in non-funded projects along with year and title ongoing
None

12. Co-investigator in funded projects along with year and title completed

YPS Balhara, Shalini Singh “Recommendations on identification and management of behavioral addictions.” Report submitted to WHO SEARO for publication. (2018).

YPS Balhara, Shalini Singh. “Review of the national policies on narcotic drugs and psychotropic substances across the South East Asia region.” Report submitted to WHO SEARO for publication. (2018)

YPS Balhara, Shalini Singh, Indrakamhaeng D. “A situation analysis of the status of policy plans and programme for addressing depressive disorders among persons with physical Non-Communicable Diseases (NCDs) and substance use disorders across the WHO South East Asian Region (SEAR).” Report submitted to WHO SEARO for publication. (2017)

YPS Balhara, Shalini Singh. “Review of secondary and tertiary prevention strategies for prevention of illicit substance use disorders. Report submitted to WHO SEARO for publication. (2016)

YPS Balhara, Shalini Singh, Arpit Parmar, Ratika Sharma “To assess burden and socio- economic cost associated with alcohol use among individuals seeking treatment at a substance use disorder treatment centre.” Report submitted to WHO SEARO for publication. (2016).

YPS Balhara, Shalini Singh, Gupta P. “Review of primary prevention strategies for prevention of illicit substance use disorders.” Report submitted to World Health Organisation South East Asian Regional Office (WHO- SEARO) for publication. (2016)

13. Co- investigator in non-funded projects along with year and title ongoing


Anxiety and apprehensions among infertile women and women planning pregnancy amidst COVID-19 Pandemic , 2020

14. Co- investigator in funded projects along with year  and title ongoing

  • An exploratory case- control study to assess the protective genetic factors against alcoholic liver disease among population from northern part of India, 2017

  • Use of online web-based applications as a platform to strengthen the services for management of addictive disorders in the state of Chhattisgarh, 2020

  • Development and evaluation of service delivery models for management of substance use disorders among the homeless population receiving urban shelter services in Delhi , 2020

  • A comparative study of melatonin and gabapentin in reducing preoperative anxiety, 2020

  • Development and evaluation of online interactive training module on mental illness and substance use disorders for health professionals of South East Asian Region, 2020

15. Co- investigator in non-funded projects along with year and title ongoing

16. Thesis supervised for MD/ PhD

- as guide (number only): not eligible yet

 

-as co-guide (number only)

  • A cross sectional study to measure the frequency of the BDNF gene polymorphism (Val66Met) in patients seeking treatment for Alcohol Dependence syndrome (ADS)

  • Feasibility of ecological momentary assessment to measure associations between perceived control over alcohol use, craving, mood and daily alcohol consumption in treatment-seeking patients of alcohol dependence syndrome

17. Significant events:

  • Member, Organising committee of the CME by the Addiction Psychiatry Society of India, January 2021

  • Member, Organising committee of the XXI Annual Conference of the International Society of Addiction Medicine, 2019

  • Completed DM Addiction Psychiatry course with aggregate 72% marks, 2018

  • Member, Organising committee of the National Conference of Addiction Psychiatry in 2017

  • Winner, Post-graduate debate at the National Conference of Addiction Psychiatry in 2017

  • Awarded the American Association of Addiction Psychiatry (AAAP) 2017 International Trainee Travel Scholarship

  • Travel award by the Indian Council of Medical Research under the International Travel Support for young scientist scheme in the year 2017

  • Member, Organising committee of the National Conference of Addiction Psychology in 2017

  • Fellow at ‘Course for Academic Development of Psychiatrists’ by the Japanese Young Psychiatrist Organization in Japan, 2016.

  • Travel award by Science & Engineering Research Board (SERB), Government of India under the International Travel Support Scheme for young scientist - 2015

 

18. other relevant information

If you want any change or rectification please Click Here

Contact Us

All India Institute of Medical Sciences

Ansari Nagar, New Delhi - 110029

Board Number : +91-11-26588500 / 26588700

Fax : +91-11-26588663 / 26588641

AIIMS Exam Section Helpline numbers ( Click Here)

Important E-mail Addresses at AIIMS

Zo2 Framework Settings

Select one of sample color schemes

Google Font

Menu Font
Body Font
Heading Font

Body

Background Color
Text Color
Link Color
Background Image

Header Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Menu Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Main Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Inset Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Bottom Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image
Background Color
Modules Title
Text Color
Link Color
Background Image
 
Top of Page